VaramirStart free · no cardSign in
HRMY as of Oct 31 · 04:30 ET
HRMYNasdaqPharmaceutical Preparations

Harmony Biosciences Holdings, Inc. · Brief

Next report

3 days

Nov 3 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 7≥ implied
avg implied
±11.3%
avg realized
±4.6%
Feb 25 '25—▲+8.16%—
May 6 '25±7.7%▲+6.98%×0.91
Aug 5 '25±13.0%▼−1.69%×0.13
Nov 4 '25±9.4%▲+4.74%×0.50
Jan 12 '26±8.4%▼−0.73%×0.09
Q1 FY26±14.4%▲+4.91%×0.34
May 7 '26±12.0%▼−4.15%×0.34
Q2 FY26±14.3%▲+8.93%×0.62
quarterimplied−15%0+15%realized×
Q2 FY26±14.3%▲+8.93%×0.62
May '26±12.0%▼−4.15%×0.34
Q1 FY26±14.4%▲+4.91%×0.34
Jan '26±8.4%▼−0.73%×0.09
Nov '25±9.4%▲+4.74%×0.50
Aug '25±13.0%▼−1.69%×0.13
2 older reports
May '25±7.7%▲+6.98%×0.91
Feb '25—▲+8.16%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 3 report · est.

Bull2

323managers reporting a position in regulatory filings13F · Jun 30 '26
+5.93%change in shares held by the largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2 of 4

38.00%share of revenue coming from the largest disclosed customer Caremark LLCSEC filings
0.05%of iShares Russell 2000 ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

HRMY report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 20impliedImplied move: ±12.7% into Nov 3 earnings (Oct 20 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.